Mammoth Biosciences News and Activities

Presence

Mammoth Biosciences develops CRISPR-based biotechnology products for gene editing, disease testing, and therapeutic research. Its tools and services support pharmaceutical companies, healthcare partners, and research organizations.

Mammoth Biosciences products and services overview:

Gene editing tools
Diagnostic tests
Therapeutic research
Molecular diagnostics
Research services

Revenue: ~$20 million

Employees: 200

Headquarters: Brisbane, United States (USA)

Mammoth Biosciences is one of the...

Executives

View the org chart displaying its 23 main executives

Most searched biographies at Mammoth Biosciences

Create your alert
to follow the executive moves at Mammoth Biosciences.

Biotechnology

Mammoth Biosciences has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
Tissium has just announced a $60 Million fundraising (posted on July 8 2026).